                         SEQUENCE LISTING

<110>  ITH Immune Therapy Holdings AB
 
<120>  TREATING MENTAL DISORDERS

<130>  P117756WO00

<160>  15    

<170>  PatentIn version 3.5

<210>  1
<211>  97
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide

<400>  1

Met Lys Val Ser Ala Ala Leu Leu Trp Leu Leu Leu Ile Ala Ala Ala 
1               5                   10                  15      


Phe Ser Pro Gln Gly Leu Ala Gly Pro Ala Ser Val Pro Thr Thr Cys 
            20                  25                  30          


Cys Phe Asn Leu Ala Asn Arg Lys Ile Pro Leu Gln Arg Leu Glu Ser 
        35                  40                  45              


Tyr Arg Arg Ile Thr Ser Gly Lys Cys Pro Gln Lys Ala Val Ile Phe 
    50                  55                  60                  


Lys Thr Lys Leu Ala Lys Asp Ile Cys Ala Asp Pro Lys Lys Lys Trp 
65                  70                  75                  80  


Val Gln Asp Ser Met Lys Tyr Leu Asp Gln Lys Ser Pro Thr Pro Lys 
                85                  90                  95      


Pro 
    


<210>  2
<211>  74
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide

<400>  2

Gly Pro Ala Ser Val Pro Thr Thr Cys Cys Phe Asn Leu Ala Asn Arg 
1               5                   10                  15      


Lys Ile Pro Leu Gln Arg Leu Glu Ser Tyr Arg Arg Ile Thr Ser Gly 
            20                  25                  30          


Lys Cys Pro Gln Lys Ala Val Ile Phe Lys Thr Lys Leu Ala Lys Asp 
        35                  40                  45              


Ile Cys Ala Asp Pro Lys Lys Lys Trp Val Gln Asp Ser Met Lys Tyr 
    50                  55                  60                  


Leu Asp Gln Lys Ser Pro Thr Pro Lys Pro 
65                  70                  


<210>  3
<211>  68
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide

<400>  3

Ser Pro Tyr Ser Ser Asp Thr Thr Pro Cys Cys Phe Ala Tyr Ile Ala 
1               5                   10                  15      


Arg Pro Leu Pro Arg Ala His Ile Lys Glu Tyr Phe Tyr Thr Ser Gly 
            20                  25                  30          


Lys Cys Ser Asn Pro Ala Val Val Phe Val Thr Arg Lys Asn Arg Gln 
        35                  40                  45              


Val Cys Ala Asn Pro Glu Lys Lys Trp Val Arg Glu Tyr Ile Asn Ser 
    50                  55                  60                  


Leu Glu Lys Ser 
65              


<210>  4
<211>  76
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (1)..(1)
<223>  X = pyroGlu or Gln

<400>  4

Xaa Pro Asp Ser Val Ser Ile Pro Ile Thr Cys Cys Phe Asn Val Ile 
1               5                   10                  15      


Asn Arg Lys Ile Pro Ile Gln Arg Leu Glu Ser Tyr Thr Arg Ile Thr 
            20                  25                  30          


Asn Ile Gln Cys Pro Lys Glu Ala Val Ile Phe Lys Thr Lys Arg Gly 
        35                  40                  45              


Lys Glu Val Cys Ala Asp Pro Lys Glu Arg Trp Val Arg Asp Ser Met 
    50                  55                  60                  


Lys His Leu Asp Gln Ile Phe Gln Asn Leu Lys Pro 
65                  70                  75      


<210>  5
<211>  76
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (1)..(1)
<223>  X = pyroGlu or Gln

<220>
<221>  X
<222>  (75)..(75)
<223>  X is K(ivDde)

<400>  5

Xaa Pro Asp Ser Val Ser Ile Pro Ile Thr Cys Cys Phe Asn Val Ile 
1               5                   10                  15      


Asn Arg Lys Ile Pro Ile Gln Arg Leu Glu Ser Tyr Thr Arg Ile Thr 
            20                  25                  30          


Asn Ile Gln Cys Pro Lys Glu Ala Val Ile Phe Lys Thr Lys Arg Gly 
        35                  40                  45              


Lys Glu Val Cys Ala Asp Pro Lys Glu Arg Trp Val Arg Asp Ser Met 
    50                  55                  60                  


Lys His Leu Asp Gln Ile Phe Gln Asn Leu Xaa Pro 
65                  70                  75      


<210>  6
<211>  76
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (1)..(1)
<223>  X = pyroGlu or Gln

<220>
<221>  X
<222>  (75)..(75)
<223>  X is an amino acid residue that can be biotinylated, such as 
       lysine, ornithine or diaminopropionic acid and optionally is 
       biotinylated, optionally via a spacer molecule such as PEG, e.g. 
       K(PEG-Biotin)

<400>  6

Xaa Pro Asp Ser Val Ser Ile Pro Ile Thr Cys Cys Phe Asn Val Ile 
1               5                   10                  15      


Asn Arg Lys Ile Pro Ile Gln Arg Leu Glu Ser Tyr Thr Arg Ile Thr 
            20                  25                  30          


Asn Ile Gln Cys Pro Lys Glu Ala Val Ile Phe Lys Thr Lys Arg Gly 
        35                  40                  45              


Lys Glu Val Cys Ala Asp Pro Lys Glu Arg Trp Val Arg Asp Ser Met 
    50                  55                  60                  


Lys His Leu Asp Gln Ile Phe Gln Asn Leu Xaa Pro 
65                  70                  75      


<210>  7
<211>  74
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (73)..(73)
<223>  X is an amino acid residue that can be biotinylated, such as 
       lysine, ornithine or diaminopropionic acid and optionally is 
       biotinylated, optionally via a spacer molecule such as PEG, e.g. 
       K(PEG-Biotin)

<400>  7

Gly Pro Ala Ser Val Pro Thr Thr Cys Cys Phe Asn Leu Ala Asn Arg 
1               5                   10                  15      


Lys Ile Pro Leu Gln Arg Leu Glu Ser Tyr Arg Arg Ile Thr Ser Gly 
            20                  25                  30          


Lys Cys Pro Gln Lys Ala Val Ile Phe Lys Thr Lys Leu Ala Lys Asp 
        35                  40                  45              


Ile Cys Ala Asp Pro Lys Lys Lys Trp Val Gln Asp Ser Met Lys Tyr 
    50                  55                  60                  


Leu Asp Gln Lys Ser Pro Thr Pro Xaa Pro 
65                  70                  


<210>  8
<211>  74
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (73)..(73)
<223>  X is K(ivDde)

<400>  8

Gly Pro Ala Ser Val Pro Thr Thr Cys Cys Phe Asn Leu Ala Asn Arg 
1               5                   10                  15      


Lys Ile Pro Leu Gln Arg Leu Glu Ser Tyr Arg Arg Ile Thr Ser Gly 
            20                  25                  30          


Lys Cys Pro Gln Lys Ala Val Ile Phe Lys Thr Lys Leu Ala Lys Asp 
        35                  40                  45              


Ile Cys Ala Asp Pro Lys Lys Lys Trp Val Gln Asp Ser Met Lys Tyr 
    50                  55                  60                  


Leu Asp Gln Lys Ser Pro Thr Pro Xaa Pro 
65                  70                  


<210>  9
<211>  74
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (73)..(73)
<223>  X is K(PEG-Biotin)

<400>  9

Gly Pro Ala Ser Val Pro Thr Thr Cys Cys Phe Asn Leu Ala Asn Arg 
1               5                   10                  15      


Lys Ile Pro Leu Gln Arg Leu Glu Ser Tyr Arg Arg Ile Thr Ser Gly 
            20                  25                  30          


Lys Cys Pro Gln Lys Ala Val Ile Phe Lys Thr Lys Leu Ala Lys Asp 
        35                  40                  45              


Ile Cys Ala Asp Pro Lys Lys Lys Trp Val Gln Asp Ser Met Lys Tyr 
    50                  55                  60                  


Leu Asp Gln Lys Ser Pro Thr Pro Xaa Pro 
65                  70                  


<210>  10
<211>  68
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide

<400>  10

Ser Pro Tyr Ser Ser Asp Thr Thr Pro Cys Cys Phe Ala Tyr Ile Ala 
1               5                   10                  15      


Arg Pro Leu Pro Arg Ala His Ile Lys Glu Tyr Phe Tyr Thr Ser Gly 
            20                  25                  30          


Lys Cys Ser Asn Pro Ala Val Val Phe Val Thr Arg Lys Asn Arg Gln 
        35                  40                  45              


Val Cys Ala Asn Pro Glu Lys Lys Trp Val Arg Glu Tyr Ile Asn Ser 
    50                  55                  60                  


Leu Glu Lys Ser 
65              


<210>  11
<211>  68
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (67)..(67)
<223>  X is K(ivDde)

<400>  11

Ser Pro Tyr Ser Ser Asp Thr Thr Pro Cys Cys Phe Ala Tyr Ile Ala 
1               5                   10                  15      


Arg Pro Leu Pro Arg Ala His Ile Lys Glu Tyr Phe Tyr Thr Ser Gly 
            20                  25                  30          


Lys Cys Ser Asn Pro Ala Val Val Phe Val Thr Arg Lys Asn Arg Gln 
        35                  40                  45              


Val Cys Ala Asn Pro Glu Lys Lys Trp Val Arg Glu Tyr Ile Asn Ser 
    50                  55                  60                  


Leu Glu Xaa Ser 
65              


<210>  12
<211>  68
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (67)..(67)
<223>  X is an amino acid residue that can be biotinylated, such as 
       lysine, ornithine or diaminopropionic acid and optionally is 
       biotinylated, optionally via a spacer molecule such as PEG, e.g. 
       K(PEG-Biotin)

<400>  12

Ser Pro Tyr Ser Ser Asp Thr Thr Pro Cys Cys Phe Ala Tyr Ile Ala 
1               5                   10                  15      


Arg Pro Leu Pro Arg Ala His Ile Lys Glu Tyr Phe Tyr Thr Ser Gly 
            20                  25                  30          


Lys Cys Ser Asn Pro Ala Val Val Phe Val Thr Arg Lys Asn Arg Gln 
        35                  40                  45              


Val Cys Ala Asn Pro Glu Lys Lys Trp Val Arg Glu Tyr Ile Asn Ser 
    50                  55                  60                  


Leu Glu Xaa Ser 
65              


<210>  13
<211>  74
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (1)..(1)
<223>  X = pyroGlu or Gln

<220>
<221>  X
<222>  (64)..(64)
<223>  X = Norleucine

<400>  13

Xaa Gly Val Phe Glu Asp Cys Cys Leu Ala Tyr His Tyr Pro Ile Gly 
1               5                   10                  15      


Trp Ala Val Leu Arg Arg Ala Trp Thr Tyr Arg Ile Gln Glu Val Ser 
            20                  25                  30          


Gly Ser Cys Asn Leu Pro Ala Ala Ile Phe Tyr Leu Pro Lys Arg His 
        35                  40                  45              


Arg Lys Val Cys Gly Asn Pro Lys Ser Arg Glu Val Gln Arg Ala Xaa 
    50                  55                  60                  


Lys Leu Leu Asp Ala Arg Asn Lys Val Phe 
65                  70                  


<210>  14
<211>  74
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (1)..(1)
<223>  X = pyroGlu or Gln

<220>
<221>  X
<222>  (64)..(64)
<223>  X = Norleucine

<220>
<221>  X
<222>  (72)..(72)
<223>  X is K(ivDde)

<400>  14

Xaa Gly Val Phe Glu Asp Cys Cys Leu Ala Tyr His Tyr Pro Ile Gly 
1               5                   10                  15      


Trp Ala Val Leu Arg Arg Ala Trp Thr Tyr Arg Ile Gln Glu Val Ser 
            20                  25                  30          


Gly Ser Cys Asn Leu Pro Ala Ala Ile Phe Tyr Leu Pro Lys Arg His 
        35                  40                  45              


Arg Lys Val Cys Gly Asn Pro Lys Ser Arg Glu Val Gln Arg Ala Xaa 
    50                  55                  60                  


Lys Leu Leu Asp Ala Arg Asn Xaa Val Phe 
65                  70                  


<210>  15
<211>  74
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthesised peptide


<220>
<221>  X
<222>  (1)..(1)
<223>  X = pyroGlu or Gln

<220>
<221>  X
<222>  (64)..(64)
<223>  X = Norleucine

<220>
<221>  X
<222>  (72)..(72)
<223>  X is an amino acid residue that can be biotinylated, such as 
       lysine, ornithine or diaminopropionic acid and optionally is 
       biotinylated, optionally via a spacer molecule such as PEG, e.g. 
       K(PEG-Biotin)

<400>  15

Xaa Gly Val Phe Glu Asp Cys Cys Leu Ala Tyr His Tyr Pro Ile Gly 
1               5                   10                  15      


Trp Ala Val Leu Arg Arg Ala Trp Thr Tyr Arg Ile Gln Glu Val Ser 
            20                  25                  30          


Gly Ser Cys Asn Leu Pro Ala Ala Ile Phe Tyr Leu Pro Lys Arg His 
        35                  40                  45              


Arg Lys Val Cys Gly Asn Pro Lys Ser Arg Glu Val Gln Arg Ala Xaa 
    50                  55                  60                  


Lys Leu Leu Asp Ala Arg Asn Xaa Val Phe 
65                  70                  


